CD47 and neoplasm: Similar study was reported by Chowdhury et al, they found that Escherichia coli vector together with nano‐based CD47 antagonist successfully promoted tumor regression and extended mice survival by stimulating the infiltration of T lymphocytes in tumor sites (Chowdhury et al., 2019).